The prevalence of thrombophilia in patients with chronic venous leg ulceration

Journal of Vascular Surgery

Volumn 35, Issue 4, 2002, Pages 718-722

  MacKenzie, Rhoda K ^a   Ludlam, Christopher A ^a   Ruckley, C Vaughan ^a   Allan, Paul L ^a   Burns, Paul ^b   Bradbury, Andrew W ^b  

^a Vascular Surgery Unit   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN A;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; RADIODIAGNOSIS; RISK FACTOR; THROMBOPHILIA; VENOUS REFLUX; BLOOD; BLOOD CLOTTING TEST; CASE CONTROL STUDY; DOPPLER ECHOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDY; VARICOSIS; VEIN THROMBOSIS;

AGED; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VARICOSE ULCER; VENOUS THROMBOSIS;

EID: 0036546297     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.121749     Document Type: Article

References (26)

1. Callam M, Ruckley C, Harper D, Dale J. Chronic ulceration of the leg: extent of the problem and provision of care. BMJ 1985;290:1855-6.
2. Laing W. Chronic venous diseases of the leg. London: Office of Health Economics; 1992.
3. Fowkes FGR. Epidemiology of chronic venous insufficiency. Phebology 1996;11:25.
4. Browse NL, Burnand KG. The cause of venous ulceration. Lancet 1982;2:243-5.
5. Milne A, Ruckley C. Venous insufficiency following deep vein thrombosis. Vasc Med Rev 1994;5:241-8.
6. Bradbury AW, Evans CJ, Allan PL, Lee AJ, Ruckley CV, Fowkes FGR. The relationship between lower limb symptoms and superficial and deep venous reflux on duplex ultrasonography: the Edinburgh Vein Study. J Vasc Surg 2000;32:921-31.
7. Stuart W, Adam D, Allan P, Ruckley C, Bradbury A. Saphenous surgery does not correct perforator incompetence in the presence of deep venous reflux. J Vasc Surg 1998;28:834-8.
8. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685-91.
9. Brittenden J, Bradbury A, Allan P, Prescott R, Harper D, Ruckley C. Popliteal vein reflux reduces the healing of chronic venous ulcer. Br J Surg 1998;85:60-2.
10. Burnand K, Thomas ML, O'Donnell T, Browse NL. Relationship between post-phlebitic changes in the deep veins and results of surgical treatment of venous ulcers. Lancet 1976;1:936-8.
11. Gloviczki P. Subfascial endoscopic perforator vein surgery: indications and results. Vasc Med 1999;4:173-80.
12. Munkvad S, Jorgensen M. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 1996;134:296-8.
13. Ribeaudeau F, Senet P, Cayuela JM, Fund X, Paul C, et al. Br J Dermatol 1999;141:259-63.
14. Alcaraz I, Levfevre I, Wiart T, Lafon C, Forzy G, Modiano P. Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases. Annales de Dermatologie et de Venereologie 1999;126:313-6.
15. Hafner J, Felten A. Resistance to activated protein C in patients with venous leg ulcers. Dermatology 1997;195:413-4.
16. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag NH, Neumann HA. The prevalence of Factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol 1999;135:41-4.
17. Van der Meer FJM, Koster T, Vandenbrouke JP, Briët E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997;78:631-5.
18. Koster T, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated Protein C: Leiden thrombophilia study. Lancet 1993;342:1503-6.
19. Rodeghiero F, Tosetto A. The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis Project. Thromb Haemost 1997;78:636-40.
20. Lowe G, Rumley A, Woodward M, Reid E, Rumley J. Activated protein C resistance and the FV:R506Q mutation in a random population sample. Thromb Haemost 1999;81:918-24.
21. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of Protein C deficiency in the healthy population. Thromb Haemost 1995;73:87-93.
22. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a co-factor to activated protein C. Proc Natl Acad Sci U S A 1993;90:1004-8.
23. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost 1999;82:1395-8.
24. Pineo GF, Hull RD. Thrombophilia: disorders predisposing to venous thromboembolism. Baillieres Clin Haematol 1998;11:525-40.
25. Lane D, Mannucci P, Bauer K, et al. Inherited thrombophilia: part 1. Thromb Haemost 1996;76:651-62.
26. Lane D, Mannucci P, Bauer K, et al. Inherited thrombophilia: part 2. Thromb Haemost 1996;76:824-34.